This page shows the latest Avastin off-licence news and features for those working in and with pharma, biotech and healthcare.
But on Friday NHS England announced it had seen off AbbVie’s challenge, issuing a triumphant press release which detailed how the judge had dismissed the case on all counts. ... off-licence in wet age-related macular degeneration.
England’s use of Avastin is not an isolated one. Health systems in other countries, including France, have also promoted its off-licence use, with a number of publicly-funded trials ... Switching to off-licence Avastin would save £100m or more, if
drug Avastin 'off- licence' to treat wet age-related macular degeneration (AMD). ... Asking Simon Stevens at NHS England to support the case for change and to support clinical commissioners who wish to make local commissioning decisions to prescribe
The Association of Greater Manchester PCTs releases a statement following reports in the Guardian yesterday that doctors were prescribing Avastin off-label for wet-AMD to avoid the high costs of ... The association of Greater Manchester PCTs has released
Primary Care Trusts (PCTs) in the Greater Manchester area in the UK have decided to offer patients Avastin off-label on the NHS, while Moorfields eye hospital in London is said ... Some doctors have reported promising results from using Avastin on an
More from news
Approximately 1 fully matching, plus 4 partially matching documents found.
We’re a specialist health consultancy that supports companies, healthcare professionals and patients to work hand in hand with a common...